Related by context. All words. (Click for frequent words.) 69 TIA transient ischemic 66 Transient ischemic attacks 66 myocardial infarction MI 66 myocardial infarction stroke 66 resuscitated cardiac arrest 65 Erythropoietic therapies may 65 nonfatal stroke 65 cerebrovascular events 65 silent ischemia 65 myocardial infarctions 65 recurrent ischemia 64 syncopal 64 ipsilateral stroke 64 urgent coronary revascularization 64 transient ischemic attacks 63 Transient Ischemic Attack 63 myocardial infarction 63 cerebrovascular accidents 63 ischemic cerebrovascular 63 ventricular tachycardia VT 62 fatal myocardial infarction 62 acute myocardial infarction AMI 62 venous thromboembolisms 62 thromboembolic 62 sustained ventricular tachycardia 62 nonfatal myocardial infarction 62 thrombotic events 62 reinfarction 62 deep vein thromboses 62 Myocardial infarction 62 coronary revascularization 62 NYHA Class II 62 left ventricular dysfunction 62 unstable angina pectoris 62 morphometric vertebral fractures 61 unstable angina 61 ischemic cardiovascular 61 nonfatal MI 61 cerebrovascular accident 61 PLX STROKE targeting 61 ST elevation myocardial 61 nonfatal myocardial infarction MI 61 arterial thromboembolic events 60 systemic embolism 60 nonischemic 60 non valvular atrial 60 myocardial infarction ventricular fibrillation 60 acute gout 60 cerebrovascular 60 acute coronary 60 stroke myocardial infarction 60 thrombo embolic 60 macrovascular 60 Exclusion criteria 60 unstable angina chest 59 ischemic complications 59 torsades de pointes 59 proximal DVT 59 coronary revascularisation 59 hypokalemia hypomagnesemia 59 Venous thromboembolism 59 carotid artery blockage 59 recurrent coronary 59 recurrent stroke 59 cerebral vascular 59 HF hospitalization 59 Angiograms carry slight 59 nontraumatic 59 lacunar 59 nonfatal cardiovascular 59 embolic stroke 59 transient ischemic attack 59 intracerebral hemorrhages 59 recurrent DVT 59 postoperative AF 59 prolonged QT interval 59 infarctions 59 acute myocardial infarctions 59 nonfatal heart 59 progressive dyspnea 59 colorectal adenoma 59 TEAEs 58 angina pectoris 58 gouty arthritis 58 myocardial infarctions MI 58 STEMIs 58 valvular heart disease 58 hypertension diabetes mellitus 58 cardiovascular ischemic 58 composite endpoint 58 pathologic fracture 58 acute myocardial infarction 58 CTEPH 58 severe exacerbations 58 rhythm disturbances 58 thromboembolism 58 cardiac dysfunction 58 repeat revascularization 58 LV dysfunction 58 patients undergoing percutaneous 58 fatal arrhythmic 58 hemorrhagic strokes 58 thromboembolic events 58 headache nasopharyngitis 58 β blockers 58 cardiovascular hospitalizations 58 aspirin clopidogrel 58 events MACE 58 angioplasties stents 58 ischemic cardiomyopathy 58 acute ischemic 58 cardioembolic 58 valvular disease 58 cardioembolic stroke 57 intracerebral hemorrhage 57 oral hypoglycemic agents 57 cardiovascular hospitalization 57 unknown etiology 57 infarcts 57 colorectal adenomas 57 nonfatal pulmonary embolism 57 myocardial infarct 57 thromboembolic disorders 57 symptomatic VTE 57 thromboembolic disease 57 ventricular arrhythmia 57 cervical spine fractures 57 intracerebral haemorrhage 57 hypertension hypercholesterolemia 57 periprocedural 57 amputation blindness 57 cerebrovascular adverse 57 myocardial infraction 57 neurologic dysfunction 57 infarction NSTEMI 57 bronchial hyperresponsiveness 57 VIIBRYD 57 macrovascular disease 57 severe hypoglycemic 57 macrovascular complications 57 hemorrhagic complications 57 renal insufficiency 57 coronary revascularization procedures 57 Severe hypoglycemia 57 autonomic dysfunction 57 heparin induced thrombocytopenia 57 acute coronary syndromes ACS 57 C1 INH deficiency 57 peripheral arterial occlusive disease 57 ventricular fibrillation VF 57 renal dysfunction 57 spinal cord compression 57 ischemia driven 57 cerebral infarction 57 lupus erythematosus 56 hypertension congestive heart 56 Hemorrhagic strokes 56 stroke hypertension palpitations 56 refractory ischemia 56 cholecystitis 56 thromboembolic complications 56 macrovascular events 56 ischemic stroke 56 LVSD 56 Relapsing remitting MS 56 peripheral artery 56 intracranial atherosclerosis 56 deep venous thromboses 56 recurrent VTE 56 hypercalcaemia 56 arterial revascularization 56 attacks TIAs 56 CHD CVD 56 vertebral fracture 56 pyrexia mucositis sepsis febrile 56 Hemorrhagic stroke 56 angina chest 56 pericardial effusion 56 symptomatic intracranial 56 ischemic cardiac 56 arterial embolism 56 ischemic vascular 56 cerebral infarctions 56 de ath 56 atherothrombosis 56 revascularization procedures 56 necrotizing pancreatitis 56 extrapyramidal symptoms 56 noncardiovascular 56 primary generalized tonic 56 Torsades de Pointes 56 reflux disease GERD 56 recurrent venous thromboembolism 56 tumor lysis syndrome 56 cryptogenic stroke 56 paroxysmal AF 56 NYHA Class III 56 venous thrombosis 55 anticoagulants blood thinners 55 decompensated heart failure 55 recurrent glioblastoma multiforme 55 segment elevation myocardial 55 rosuvastatin #mg 55 unstable angina UA 55 gallbladder disease 55 aneurysmal subarachnoid hemorrhage 55 levodopa induced 55 salmeterol HFA MDI 55 artery reclogging 55 hyperacute 55 Ischemic strokes 55 Postoperative complications 55 hepatic failure 55 venous thromboembolic 55 rebleeding 55 cerebral vasospasm 55 diabetes mellitus hypertension 55 deCODE MI TM 55 Pulmonary embolism 55 VaD 55 venous thromboembolism VTE 55 MIs 55 venous thromboembolic disease 55 pulmonary dysfunction 55 VT VF 55 nondiabetic patients 55 macroalbuminuria 55 KIF6 carriers 55 revascularisation 55 Myocardial Infarction MI 55 pulmonary toxicity 55 acutely decompensated congestive heart 55 infarction STEMI 55 vasovagal 55 asthma exacerbation 55 myocardial ischemia 55 CVD mortality 55 NYHA class 55 Uncontrolled hypertension 55 variant angina 55 chronic thromboembolic pulmonary 55 intracerebral hemorrhage ICH 55 dysglycemia 55 heart palpitations dizziness 55 haemorrhagic stroke 55 venous thrombotic events 55 elevated fasting glucose 55 intracranial bleeding 55 electrolyte abnormalities 55 ischemic 55 Unstable Angina 55 cerebral embolism 55 asymptomatic PAD 55 recurrent myocardial infarction 55 hypertension dyslipidemia 55 carotid atherosclerosis 55 stent thromboses 55 myocardial infarctions MIs 55 angiotensin converting enzyme inhibitor 55 acute decompensation 55 thromboses 55 convulsive disorders 55 thyrotoxicosis 55 ocular adverse 55 angiotensin converting enzyme inhibitors 55 death reinfarction 55 lumiracoxib 55 causally related 55 ATACAND 55 ventricular tachyarrhythmia 54 Ischemic stroke 54 myocardial infarction congestive heart 54 cerebral ischemia 54 Hypotension 54 ischemic strokes 54 MACCE 54 haematologic 54 Ischemic 54 NATRECOR ® 54 hypercalcemia 54 Diabetic nephropathy 54 angioedema 54 cryptogenic 54 onset atrial fibrillation 54 IIIa inhibitor 54 nonfatal cardiac arrest 54 antiphospholipid syndrome 54 atherothrombotic disease 54 bleeding diathesis 54 recurrent ischemic stroke 54 symptomatic pulmonary embolism 54 left ventricular systolic 54 confirmed thrombotic cardiovascular 54 polyarticular 54 PROactive study 54 Lupus nephritis 54 NATRECOR R 54 neutropenia dehydration dyspnea 54 nonvertebral fracture 54 oral antidiabetic medication 54 nadolol 54 multivariate adjustment 54 severe hypoglycemia 54 rosuvastatin Crestor 54 pathologic fractures 54 somnolence dizziness 54 syncope fainting 54 peri procedural 54 atherothrombotic 54 neurologic complications 54 papilledema 54 Tardive dyskinesia 54 QT prolongation 54 hypoglycaemic 54 arterial hypertension 54 carotid stenosis 54 beta blockers ACE inhibitors 54 claudication 54 defibrillator CRT D 54 death dissection perforation 54 carotid artery stenting CAS 54 hypoxemia 54 cardiovascular mortality 54 chronic obstructive lung 54 arterial calcification 54 tachyarrhythmias 54 stable angina 54 subarachnoid hemorrhages 54 elevation acute coronary 54 rFVIIa 54 hypoglycaemic episodes 54 thromboembolisms 54 ARCOXIA 54 Treatment emergent adverse 54 angina 54 recurrent atrial fibrillation 54 nonvertebral fractures 54 metformin sulfonylurea 54 Lactic acidosis 54 nonrandomized 54 DVT PE 54 nasopharyngitis headache 54 subarachnoid hemorrhage SAH 54 acute coronary syndrome 54 potassium sparing diuretics 54 Sezary syndrome 54 microvascular disease 54 elevated triglyceride levels 53 Renal impairment 53 syncope 53 metachronous 53 hypokalemia 53 severe neutropenia 53 NYHA 53 dermatologic reactions 53 symptomatic atrial fibrillation 53 apnea hypopnea 53 undergoing coronary artery 53 torsade de pointes 53 NSTEMI 53 Carotid Revascularization Endarterectomy vs. 53 valvular heart 53 reoperations 53 EEG abnormalities 53 Transient Ischaemic Attack 53 Heavy snorers 53 fulminant hepatitis 53 fatal pulmonary embolism 53 STEMI ST 53 Acute myocardial infarction 53 Peripheral arterial disease 53 Coronary artery bypass grafting 53 microbleeds 53 microvascular complications 53 subclinical hypothyroidism 53 salmeterol fluticasone 53 atrioventricular valve 53 optic neuropathy 53 eplerenone 53 CP CPPS 53 Renal dysfunction 53 antiarrhythmic medications 53 inhospital 53 vein thrombosis 53 receiving ISENTRESS 53 gastrointestinal perforations 53 Hip fracture 53 Events MACE 53 CARE HF 53 Subarachnoid hemorrhage 53 Pulmonary edema 53 ximelagatran 53 noncardiac surgery 53 supraventricular arrhythmias 53 liver decompensation 53 onset seizures 53 impaired cognition 53 lipid lowering agents 53 subtrochanteric 53 angioplasty stenting 53 benazepril 53 femoral neck fracture 53 revascularizations 53 TAXUS Express Stent 53 ventricular remodeling 53 Intracerebral hemorrhage 53 undergoing CABG 53 Idiopathic pulmonary fibrosis IPF 53 Diabetic neuropathy 53 cerebrovascular disease 53 Impaired glucose tolerance 53 hypoglycemic episodes 53 intracerebral 53 FluCAM arm 53 QRS duration 53 Atherosclerotic 53 QT intervals 53 dysrhythmias 53 receiving XGEVA 53 treatment emergent adverse 53 Vascular dementia 53 Thrombolysis 53 upper gastrointestinal bleeding 53 asystole 53 seizures miscarriages 53 coronary intervention 53 receiving VELCADE 53 gastro esophageal reflux disease 53 keloid scarring 53 NMIBC 53 definite stent thrombosis 53 cerebrovascular diseases 53 atherosclerotic disease 53 pulmonary thromboembolism 53 Eisenmenger syndrome 53 thrombocytopenic 53 β blocker 53 COREG 53 ANCA associated 53 atrial tachyarrhythmias 53 Coronary artery calcification 53 hypopneas 53 traumatic amputations 53 hypoglycemic events 53 headache abdominal pain 53 fatal hemorrhagic 53 generalized tonic clonic seizures 53 AGGRASTAT ® tirofiban hydrochloride 53 haemorrhagic strokes 53 HMG CoA reductase inhibitors 53 Acute coronary syndromes 53 Avandia Actos 53 paroxysmal 53 dyslipidemia hypertension diabetes 53 convulsive seizures 53 pathophysiologic 53 carotid endarterectomy CEA 53 Stent thrombosis 53 Deep vein thrombosis 53 amenorrhoea 53 COPD exacerbation 53 thiazolidinediones TZDs 53 recurrent acute pancreatitis 53 neuropathies 53 undergoing coronary angiography 53 laboratory abnormalities 53 ministroke 53 arrythmias 52 MIRAPEX 52 XIENCE V PROMUS Stent 52 aneurysm ruptures 52 coronary artery clots 52 intraventricular hemorrhage 52 RE LY ® 52 neutropenia thrombocytopenia 52 HeFH 52 radicular pain 52 hematologic adverse 52 prothrombotic 52 TAXUS p value 52 preserved ejection fraction 52 discontinuations due 52 recombinant tissue plasminogen 52 dyslipidemia hypertension 52 proliferative retinopathy 52 antithrombotic therapies 52 sinus bradycardia 52 endometrial hyperplasia 52 pericardial effusions 52 symptomatic DVT 52 acute myocardial infarction MI 52 NSAID induced 52 arterial thrombosis 52 symptomatic hyponatremia 52 renal flares 52 lower extremity amputation 52 ExTRACT TIMI 52 anticoagulant warfarin 52 bronchospasm 52 atherothrombotic events 52 nonaspirin 52 Arrhythmogenic Right Ventricular Cardiomyopathy 52 Val HeFT 52 arrhythmogenic 52 inhaled bronchodilators 52 NNT = 52 atherosclerotic cardiovascular 52 pulmonary embolisms 52 hepatic renal 52 olmesartan 52 left ventricular hypertrophy 52 Acute Exacerbations 52 prostate cancer CaP 52 cytopenias 52 connective tissue disorders 52 atrioventricular block 52 nonalcoholic steatohepatitis 52 anticlotting drugs 52 drug eluting stent implantation 52 generalized edema 52 uncontrolled hypertension 52 mcg QD 52 inappropriate antidiuretic hormone SIADH 52 postoperative pulmonary 52 QTc intervals 52 coronary thrombosis 52 underwent CABG 52 fragility fracture 52 ticlopidine 52 Ranolazine 52 hemorrhagic bleeding 52 atrophic gastritis 52 periprocedural MI 52 idiopathic PD 52 lung cancer NSCLC 52 Infusion Reactions Severe 52 Alzheimer disease vascular dementia 52 antiplatelet drugs 52 intracranial hemorrhage ICH 52 artery stenosis 52 Kaplan Meier curve 52 carotid artery narrowing 52 XIENCE V demonstrated 52 Arch Intern Med 52 stable angina pectoris 52 coexisting illnesses 52 cerebral ischemic 52 proliferative diabetic retinopathy 52 diabetic kidney 52 venous thromboembolism 52 hepatic insufficiency 52 myocardial infarcts 52 artery occlusion 52 ARIXTRA 52 acute coronary syndromes 52 renal scarring 52 antithrombotic therapy 52 hyperglycaemia 52 multivariate Cox 52 NIDDM 52 PRADAXA #mg 52 concomitant medications 52 mycosis fungoides 52 primidone 52 lipid lowering drugs 52 untreated OSA 52 PAOD 52 paroxysmal atrial fibrillation 52 myocardial fibrosis 52 pain hypotension CVA 52 kidney urologic 52 esophageal perforation 52 Ventricular Tachycardia 52 Angiotensin receptor blockers 52 neurologic symptoms 52 cervicitis 52 keloid scarring treatment 52 endobronchial 52 myocardial ischemic events 52 anticholinergic medication 52 fibrosing 52 AVANDIA 52 infarction 52 variceal bleeding 52 palpitations shortness 52 primary hyperparathyroidism 52 paclitaxel eluting stents 52 coronary stenosis 52 anti arrhythmic drugs 52 antiarrhythmic drug 52 impaired glucose metabolism 52 carotid artery stenosis 52 nonarteritic anterior ischemic optic 52 intracranial stenosis 52 Febrile neutropenia 52 COX inhibitors 52 IPAH 52 fragility fractures 52 tibolone 52 osteoarthritis rheumatoid arthritis 52 stress cardiomyopathy 52 oral antidiabetic drugs 52 heart arrhythmias 52 constipation nausea 52 sensory disturbances 52 mitral insufficiency 52 multiple sclerosis cerebral palsy 52 hypoventilation 52 overt nephropathy 52 fibrinolysis 52 Syncope 52 tamoxifen Nolvadex ® 52 onset diabetes mellitus 52 prospectively defined 52 interstitial pneumonitis 52 obstructive coronary 52 recurrent ischemic 52 hyperparathyroidism 52 endometrial carcinoma 52 malignant neoplasms 52 cardiogenic shock 52 noncardiovascular mortality 52 coronary revascularizations 52 clinically meaningful reductions 52 neurologic sequelae 52 TIAs 52 elevation myocardial infarction 52 predisposing factor 52 atherosclerotic CVD 52 congestive cardiac 52 Atrial flutter 52 thrombotic 52 intravenous bisphosphonates 52 ventricular tachyarrhythmias 52 nicardipine 52 postoperative delirium 52 intravitreal injections 51 symptomatic hypoglycemia 51 venous thromboembolic events 51 generalized seizures 51 ACTOplus met 51 bullous 51 tachyarrhythmia 51 EXJADE 51 paroxetine Paxil 51 systemic corticosteroid 51 fibrosis scarring 51 pseudoaneurysms 51 percutaneous interventions 51 NYHA functional class 51 vertebral fractures 51 paresthesias 51 preserved systolic 51 antiplatelet medications 51 subarachnoid haemorrhage 51 TNF antagonist 51 ICD implantation 51 intraoperative complications 51 transcatheter closure 51 ACUITY trial 51 urate lowering 51 INTERHEART study 51 acute HAE 51 hypercholesterolaemia 51 metabolic dysfunction 51 postoperative atrial fibrillation 51 coagulopathy 51 antiarrhythmic agents 51 sirolimus stent 51 perioperative complications 51 intra abdominal abscess 51 sinus node dysfunction 51 incidence ≥ 51 NIASPAN 51 postintervention 51 hepatotoxicity 51 percutaneous transluminal coronary angioplasty 51 cerebral microbleeds 51 rhythm abnormalities 51 atrial fibrillation AF 51 hyperalgesia 51 intravenous cyclophosphamide 51 gangrene amputation 51 CABG coronary artery 51 autoimmune reactions 51 nonfasting triglyceride levels 51 stratifying patients 51 calcaneal fractures 51 bowel perforations 51 cardiac ischemia 51 chronic renal insufficiency 51 underwent coronary angiography 51 surgically induced 51 Cerebrovascular 51 thiazolidinedione TZD 51 postoperative mortality 51 meta regression 51 beta blocker therapy 51 giant cell arteritis 51 MGUS 51 hypopnea 51 cardiac tamponade 51 irregular quivering 51 VTE 51 headache nausea fatigue 51 PREZISTA r arm 51 hereditary antithrombin deficient 51 post thrombotic syndrome 51 systemic juvenile idiopathic 51 Percutaneous Coronary Intervention 51 impaired fasting glucose 51 APTIVUS r 51 conjunctival hyperemia 51 DES implantation 51 Phase IIb acute ischemic 51 diarrhea nausea vomiting 51 lungs pulmonary embolism 51 hyperammonemia 51 ischemic optic neuropathy 51 Asymptomatic 51 Primary Hypercholesterolemia 51 XIENCE V vs. 51 Sleep disturbances 51 hepatocellular 51 immunodeficiencies 51 recurrent wheezing 51 severe obstructive pulmonary 51 Idiopathic 51 nonhereditary 51 coronary disease 51 apnea hypopnea index 51 angiotensin II receptor blockers 51 Prehypertension 51 granulomatous 51 pulmonary emboli 51 ventricular dysfunction 51 prolonged QT intervals 51 Mitral regurgitation 51 mixed hyperlipidemia 51 Myocardial Infarction Study 51 incomplete revascularization 51 bypass graft CABG surgery 51 MI myocardial infarction 51 gastric varices 51 abnormal lipids 51 CRVO 51 arterial venous 51 encephalitis meningitis 51 supraventricular tachycardia SVT 51 lopinavir r arm 51 cerebral vascular accident 51 myocardial ischaemia 51 recurrent clotting 51 homozygous familial hypercholesterolemia 51 occlusive disease 51 ECASS 51 neurovascular diseases 51 CRESTOR #mg 51 jaw necrosis 51 ECG abnormalities 51 distal embolization thrombus formation 51 unfractionated heparin 51 Excessive daytime sleepiness 51 ß blockers 51 intermittent claudication 51 Estrogen deficiency 51 hepatorenal syndrome 51 postoperative complication 51 arterial occlusion 51 CC genotype 51 suppurative 51 lumbar disk herniation 51 ACTOS ® 51 hyperlipidaemia 51 glycated hemoglobin levels 51 psychological aftereffects 51 left ventricular diastolic 51 #.#mg/dL 51 thrombolytic agents 51 thyrotropin levels 51 relapsing remitting MS RRMS 51 ketoacidosis hyperosmolar coma 51 lactic acidosis 51 transaminase elevations 51 pulmonary exacerbation 51 hyperhomocysteinemia 51 stent implantation 51 fatal anaphylactic 51 thrombolytic therapy 51 QTc interval 51 cardiomyopathies 51 either acutely decompensated 51 psychiatric comorbidities 51 venous hypertension 51 esophageal gastric 51 renal impairment 51 ST Segment Elevation 51 CIMZIA ™ 51 QTc 51 severe hypoglycaemia 51 progressive neurodegenerative disorder 51 Adjuvant chemotherapy 51 VTEs 51 Major Adverse Cardiac 51 affective psychoses 51 ICD shocks 51 Clogged arteries 51 coronary blockages 51 haemorrhagic 51 hyperpyrexia 51 Nesiritide 51 placebo controlled clinical 51 pneumonectomy 51 esophageal reflux 51 hemiparesis 51 UA NSTEMI 51 subsyndromal 51 adjunctive placebo 51 headache nausea diarrhea 51 decompensation 51 systemic autoimmune 51 pulmonary resection 51 confidence interval #.#-#.# 51 etiologic 51 neurologic impairment 51 AA Amyloidosis 51 insulin resistance syndrome 51 venous blood clots 51 renal toxicity 51 affective psychosis 51 ABCB1 51 treating acute ischemic 51 superior mesenteric artery 51 oral anticoagulation therapy 51 APOE e4 51 thrombosis 51 G6PD deficiency 51 metoprolol tartrate 51 neuropsychiatric adverse 50 asymptomatic carotid stenosis 50 severe mitral regurgitation 50 Hurthle cell 50 desvenlafaxine succinate 50 myoclonus 50 anterior uveitis 50 coronary artery occlusion 50 hemodynamic instability 50 dopaminergic therapy 50 peptic ulcer 50 atherogenic dyslipidemia 50 NSTE ACS 50 patients undergoing CABG 50 flutamide 50 primary percutaneous coronary 50 arterial thrombotic 50 Paroxysmal 50 deep venous thrombosis 50 enalapril 50 ejection fractions 50 candesartan cilexetil 50 DVT blood clot 50 rosiglitazone maleate 50 binary restenosis 50 brain infarcts 50 #mg/dl 50 zolmitriptan 50 vasospasm 50 rofecoxib 50 Mitral valve 50 diarrhea headache nausea 50 sertraline Zoloft 50 troponin T 50 subclinical atherosclerosis 50 del 5q MDS 50 noncarriers 50 unresectable HCC 50 hyperreflexia 50 corticosteroid therapy 50 QTc prolongation 50 venlafaxine Effexor 50 dilated cardiomyopathy DCM 50 tolvaptan 50 IBS C 50 hemorrhagic cystitis 50 lobectomy 50 coronary insufficiency 50 diabetes mellitus 50 CV thrombotic 50 lipid lowering medication 50 Disease GOLD 50 metastatic malignant 50 parkinson disease 50 aldosterone antagonist 50 poststroke 50 hyperphenylalaninemia HPA due 50 neutropaenia 50 CHD mortality 50 exacerbations 50 arteriography 50 chronic metabolic acidosis 50 endometriosis ovarian cysts 50 partial onset seizures 50 severe renal insufficiency 50 cerebral vascular disease 50 dalteparin 50 Carotid endarterectomy 50 gastrointestinal perforation 50 interstitial pneumonia 50 systemic lupus erythematosus 50 vascular inflammation 50 Acute Myocardial Infarction 50 vulvovaginal atrophy 50 paraganglioma 50 tachycardias 50 liver metastasis 50 microalbuminuria 50 coronary atherosclerosis 50 multi infarct dementia 50 ADHF 50 intermittent hypoxia 50 sirolimus eluting stents 50 nonfatal myocardial infarctions 50 nonoperative treatment 50 neuropathological 50 DULERA 50 loop diuretics 50 nonmelanoma skin cancer 50 STRIDE PD 50 clot busting therapy 50 computed tomography angiography 50 secondary hyperparathyroidism 50 Exacerbations 50 angiotensin converting enzyme ACE 50 leukopenia 50 pulmonary hypertension PH 50 arthropathy 50 thiazolidinedione 50 thrombophlebitis 50 % CI #.#-#.# [006] 50 AML MDS 50 bronchogenic carcinoma 50 nonalcoholic steatohepatitis NASH 50 Progressive Multifocal Leukoencephalopathy PML 50 Untreated sleep apnea 50 pulmonary infiltrates 50 nonmelanoma skin cancers 50 pacemaker implantation 50 non selective NSAIDs 50 aldosterone antagonists 50 extrapyramidal disorder 50 serum phosphorous 50 noncardiac 50 pulmonary embolism PE 50 thienopyridines 50 knee osteoarthritis OA 50 diabetic gastroparesis 50 primary hypercholesterolemia 50 anovulatory infertility 50 bezafibrate 50 glitazones 50 Deep venous thrombosis 50 neurologic deficits 50 diabetes dyslipidemia 50 psoriatic arthritis PsA 50 VADT 50 Hashimoto thyroiditis 50 events SAEs 50 modified REGENESIS Phase IIb 50 infarct size 50 Ischaemic heart 50 primary aldosteronism 50 pancytopenia 50 Coronary artery bypass graft 50 Gorlin syndrome 50 spontaneous preterm delivery 50 MADIT II 50 pulmonary embolus 50 selective NSAIDs 50 carotid plaque 50 lamotrigine 50 advanced adenoma 50 asplenia 50 patientswith 50 Crestor Lipitor 50 vaso occlusive crisis 50 oxycodone CR 50 neurologic abnormalities 50 cilostazol 50 TAVR 50 virologic failure 50 neovascular diseases 50 dyslipidaemia 50 Critical limb ischemia 50 pulmonary artery banding 50 vomiting drowsiness 50 Operative mortality 50 bowel resection 50 idiopathic Parkinson disease 50 adenoma recurrence